Skip to main content
. 2015 Jul 8;19(3):207–213. doi: 10.5114/wo.2015.52656

Table 2.

The relationship between survival and ERCC1 and RRM1 expression in lung, ovarian and pancreas cancer

Median 95% confidence interval Median 95% confidence interval p
NSCLC ERCC1 Low 23.3 15.8–30.6 18 12.4–23.5 0.001
High 10.2 8.1–12.2 9 6.2–11.7
RRM1 Low 20.9 14.3–27.5 15 11.8–18.1 0.029
High 10.9 8.3–13.5 9 5.5–12.4
Ovarian cancer ERCC1 Low 30.0 23–37 27 17.8–36.1 0.183
High 15.8 9.3–22.4 10 0–23.8
RRM1 Low 29.3 21.1–37.5 27 15.8–38.1 0.490
High 20.1 14.3–26 23 10.7–35.2
Pancreas cancer ERCC1 Low 16.7 12.9–20.5 18 11.4–24.5 0.684
High 17.4 9.3–25.4 12 6.8–17.1
RRM1 Low 21.6 14.9–28.4 18 15–20.9 0.005
High 9.6 5.5–13.7 7 1–13